The Ulan-Ude Nuclear Medicine Center (UMC) is one of the leading full-cycle medical facilities in the Russian Far East. It develops and produces radiopharmaceuticals and uses them to diagnose cancer at the earliest stages. UMC conducts over 10,000 examinations annually.
The investment project is being implemented under an agreement with the Far East and Arctic Development Corporation (FEDC) and a concession agreement with the Government of the Republic of Buryatia, represented by the republic's Ministry of Health. The total project cost is 1.4 billion rubles, including a capital grant of 400 million rubles from the Presidential Unified Subsidy (overseen by the Ministry for the Development of the Russian Far East and FEDC) under the concession agreement.
